News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Announces Collaboration with Schering-Plough Corporation (SGP) for Design and Synthesis of Novel Compounds


11/8/2007 12:08:22 PM

RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) group of companies (NASDAQ Capital Market:CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has entered into a service agreement with Schering-Plough Corporation (NYSE:SGP) to design, synthesize and purify high-quality, drug-like compounds to expand the compound file collection of Schering-Plough Research Institute (SPRI), the company’s research and development arm.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES